ALX ONCOLOGY INC
ALXOLatest QuantConomy context for ALXO: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
ALX ONCOLOGY INC
QuantConomy has a structured record for ALXO. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- ALXO
- Name
- ALX ONCOLOGY INC
- Coverage
- 3 market/data records
- Sources
- alphavantage alpaca fmp sec nasdaq
Recent signals for ALXO
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| corporate event material agreement | bullish | 95 | Jun 26, 08:26 PM | ALXO filed 8-K: Material Definitive Agreement, Termination of Material Agreement, Direct Financial Obligation - 3 material events - [very strong bullish signal] |
| earnings earnings release | neutral | 40 | Feb 27, 12:00 AM | ALXO filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-27. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings earnings release | neutral | 40 | May 8, 12:00 AM | ALXO filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-05-08. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| ALXO | NASDAQ | alphavantage | Alx Oncology Holdings Inc |
| ALXO | NASDAQ | alpaca | ALX Oncology Holdings Inc. Common Stock |
| ALXO | NASDAQ | fmp | ALX Oncology Holdings Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Wong Shelly | SVP, FINANCE AND CAO | sale | 1,404 | $2.04 | $2,864 | 4 on EDGAR |
| Apr 16, 2026 | Knight Jeff E. | Chief Dev & Operating Officer | grant | 800,000 | — | — | 4 on EDGAR |
| Apr 16, 2026 | Klencke Barbara | Chief Medical Officer | grant | 100,000 | — | — | 4 on EDGAR |
| Mar 19, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | sale | 903 | $2.17 | $1,960 | 4 on EDGAR |
| Mar 19, 2026 | Lettmann Jason | CHIEF EXECUTIVE OFFICER | sale | 12,311 | $2.17 | $26,715 | 4 on EDGAR |
| Mar 3, 2026 | Klencke Barbara | Chief Medical Officer | grant | 700,000 | — | — | 4 on EDGAR |
| — | Klencke Barbara | Chief Medical Officer | — | — | — | — | 3 on EDGAR |
| Feb 18, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | sale | 565 | $2.27 | $1,283 | 4 on EDGAR |
| Feb 17, 2026 | Lettmann Jason | CHIEF EXECUTIVE OFFICER | other | 2,201 | $2.27 | $4,996 | 4 on EDGAR |
| Feb 2, 2026 | GOODMAN COREY S | Director, 10% owner | purchase | 3,184,713 | $1.57 | $4,999,999 | 4 on EDGAR |
| Jan 26, 2026 | Lettmann Jason | CHIEF EXECUTIVE OFFICER | grant | 912,000 | — | — | 4 on EDGAR |
| Jan 26, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | grant | 192,000 | — | — | 4 on EDGAR |
| Jan 26, 2026 | Shantharam Harish | Chief Financial Officer | grant | 303,000 | — | — | 4 on EDGAR |
| Jan 20, 2026 | Garland J. Scott | Director | grant | 40,400 | — | — | 4 on EDGAR |
| Jan 20, 2026 | Sandler Alan B. | Director | grant | 10,100 | — | — | 4 on EDGAR |
| Jan 20, 2026 | Hemrajani Rekha | Director | grant | 40,400 | — | — | 4 on EDGAR |
| Jan 20, 2026 | Curran Daniel J. | Director | grant | 16,833 | — | — | 4 on EDGAR |
| Jan 20, 2026 | Takimoto Chris H | Director | grant | 40,400 | — | — | 4 on EDGAR |
| Jan 20, 2026 | GOODMAN COREY S | Director, 10% owner | grant | 40,400 | — | — | 4 on EDGAR |
| Jan 6, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | sale | 3,925 | $1.11 | $4,357 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query ALXO context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access